Ni, Yi
Zhang, Zhenfeng
Engelskircher, Lisa
Verch, Georg
Tu, Thomas http://orcid.org/0000-0002-0482-4387
Lempp, Florian A.
Urban, Stephan
Funding for this research was provided by:
German Center for infectious diseases (DZIF) project
Article History
Received: 18 January 2019
Accepted: 25 June 2019
First Online: 10 July 2019
Competing Interests
: Stephan Urban is co-applicant and co-inventor on patents protecting HBV preS-derived lipopeptides (Myrcludex B) for the use of HBV/HDV entry inhibitors. The other authors in this study declare nothing to disclose.